Brit Fitzner
Impact in
-
- Multiple Sclerosis Research Studies
- Immunology top 10%
- Phagocytosis and Immune Regulation
Papers in
- Aging 1
-
- Multiple Sclerosis Research Studies 10
- Co-authors
- Uwe K. ZettlRobert JasterMichael HeckerGisela SparmannStefan LiebeJörg EmmrichFlorian DeisenhammerHenrik Zetterberg
- Journals
- Cellular Signalling (4 papers)World Journal of Gastroenterology (2 papers)Autoimmunity Reviews (2 papers)Frontiers in Immunology (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- GermanyAustriaUnited Kingdom
In The Last Decade
Brit Fitzner
41 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Pathology and Forensic Medicine 267
- Immunology 300
- Oncology 317
- Aging 20
- Rheumatology 128
Countries citing papers authored by Brit Fitzner
This map shows the geographic impact of Brit Fitzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brit Fitzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brit Fitzner more than expected).
Fields of papers citing papers by Brit Fitzner
This network shows the impact of papers produced by Brit Fitzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brit Fitzner. The network helps show where Brit Fitzner may publish in the future.
Co-authors
The 25 scholars most cited alongside Brit Fitzner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 4 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 115 | |
| 7 | 2018 | 19 | |
| 8 | 2018 | 14 | |
| 9 | 2016 | 15 | |
| 10 | 2015 | 51 | |
| 11 | 2014 | 18 | |
| 12 | 2014 | 2 | |
| 13 | 2013 | 50 | |
| 14 | 2013 | 7 | |
| 15 | 2009 | 10 | |
| 16 | 2009 | 13 | |
| 17 | 2008 | 15 | |
| 18 | 2008 | 27 | |
| 19 | 2006 | 26 | |
| 20 | 2004 | 22 |
About Brit Fitzner
Brit Fitzner is a scholar working on Aging, Pathology and Forensic Medicine, Immunology, Oncology and Rheumatology, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (16 papers), Multiple Sclerosis Research Studies (10 papers), Pancreatic and Hepatic Oncology Research (9 papers), RNA regulation and disease (5 papers), IgG4-Related and Inflammatory Diseases (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Sphingolipid Metabolism and Signaling (4 papers) and Telomeres, Telomerase, and Senescence (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (267 citations), Immunology (300 citations), Oncology (317 citations), Aging (20 citations) and Rheumatology (128 citations). Brit Fitzner has collaborated with scholars based in Germany, Austria and United Kingdom. Frequent co-authors include Uwe K. Zettl, Robert Jaster, Michael Hecker, Gisela Sparmann, Stefan Liebe, Jörg Emmrich, Florian Deisenhammer, Henrik Zetterberg, Hans‐Jürgen Thiesen and Peter Brock. Their work appears in journals such as Cellular Signalling, World Journal of Gastroenterology, Autoimmunity Reviews, Frontiers in Immunology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.